Geriatrics. 2005 Jun;Suppl:9-14.

Mild cognitive impairment and preclinical Alzheimer's disease.

Source

Department of Neurology, Washington University School of Medicine, 4488 Forest Park Avenue, Suite 101, St. Louis, MO 63108, USA. morrisj@abraxas.wustl.edu

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by a gradual decline of numerous cognitive processes, culminating in dementia. Mild cognitive impairment (MCI) is a relatively broad clinical condition involving a slight memory deficit, which in many cases represents a transitional state between normal cognition and AD. Much research is currently being conducted on MCI, since any therapy that is effective at treating this early manifestation of dementia may provide an opportunity for managing the disease while patient function is relatively preserved. Current research seeks to develop disease-modifying treatments that intervene in the pathobiologic processes involved in MCI and AD. Another goal of current research is to develop antecedent biomarkers that can be used to detect AD prior to the appearance of symptoms and before substantial and irreversible brain damage occurs.

PMID:: 16025770; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

EBSCO

Other Literature Sources

Medical

Molecular Biology Databases

MEMANTINE - HSDB

Supplemental Content

Related citations

[Alzheimer drugs for mild cognitive impairment]. [Neuropsychiatr. 2007]
[Alzheimer drugs for mild cognitive impairment].
Fellgiebel A. Neuropsychiatr. 2007; 21(3):230-3.
Review Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. [Clin Ther. 2006]
Review Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A, Lah J, Goldstein F, Steenland K, Bliwise D. Clin Ther. 2006 Jul; 28(7):991-1001.
Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function. [J Integr Neurosci. 2007]
Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function.
Liddell BJ, Paul RH, Arns M, Gordon N, Kukla M, Rowe D, Cooper N, Moyle J, Williams LM. J Integr Neurosci. 2007 Mar; 6(1):141-74.
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. [Trials. 2009]
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
Jones R, Sheehan B, Phillips P, Juszczak E, Adams J, Baldwin A, Ballard C, Banerjee S, Barber B, Bentham P, et al. Trials. 2009 Jul 24; 10:57. Epub 2009 Jul 24.
Review Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. [J Clin Psychiatry. 2006]
Review Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN. J Clin Psychiatry. 2006; 67 Suppl 3:15-22; quiz 23.

See reviews... See all...

Cited by 8 PubMed Central articles

Amyloid imaging and memory change for prediction of cognitive impairment. [Alzheimers Res Ther. 2011]
Amyloid imaging and memory change for prediction of cognitive impairment.
Resnick SM, Sojkova J. Alzheimers Res Ther. 2011 Jan 31; 3(1):3. Epub 2011 Jan 31.
Hierarchical cognitive and psychosocial predictors of amnestic mild cognitive impairment. [J Int Neuropsychol Soc. 2010]
Hierarchical cognitive and psychosocial predictors of amnestic mild cognitive impairment.
Han SD, Suzuki H, Jak AJ, Chang YL, Salmon DP, Bondi MW. J Int Neuropsychol Soc. 2010 Jul; 16(4):721-9.
Blockade of GABA(B) receptors completely reverses age-related learning impairment. [Neuroscience. 2009]
Blockade of GABA(B) receptors completely reverses age-related learning impairment.
Lasarge CL, Bañuelos C, Mayse JD, Bizon JL. Neuroscience. 2009 Dec 15; 164(3):941-7. Epub 2009 Aug 31.

See all...

Chemical compound information

Memantine

MW: 215.76 g/mol

MF: C₁₂H₂₂ClN

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Mild cognitive impairment and preclinical Alzheimer's disease.
Mild cognitive impairment and preclinical Alzheimer's disease.
Geriatrics. 2005 Jun ;Suppl:9-14.

PubMed
Treatments for Alzheimer disease.
Treatments for Alzheimer disease.
South Med J. 2005 Jun ;98(6):628-35.

PubMed
Current epidemiology of mild cognitive impairment and other predementia syndrome...
Current epidemiology of mild cognitive impairment and other predementia syndromes.
Am J Geriatr Psychiatry. 2005 Aug ;13(8):633-44.

PubMed
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's...
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
Science. 1994 Mar 4 ;263(5151):1281-4.

PubMed
IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette s...
IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung.
Am J Respir Cell Mol Biol. 2008 Jun ;38(6):689-98. Epub 2008 Jan 31 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Mild cognitive impairment and preclinical Alzheimer's disease.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 8 PubMed Central articles

Chemical compound information

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information